Cellworks Research India Ltd is helping Orchid Chemicals & Pharmaceuticals Ltd, in its ongoing New Chemical Entity research program.

According to Dr.C. Bhaktavatsala Rao, Deputy Managing Director, Orchid Chemicals & Pharmaceuticals Ltd, "The need to understand the detailed mechanisms of actions, biological targets and associated pros and cons of the landscape of key drugs is essential for a differentiated New Molecule Entity project. We've been closely working with theCellworks solution for one of our key internal Drug Discovery projects and were able to quickly ascertain which biological receptor target to focus on. We believe that the adoption of the Systems Biology platform from Cellworks will significantly improve our overall Drug discovery methodology. Close collaboration with Cellworks expands our disease biology skills and enables us to deliver better efficacy drugs with contained side-effects to our customers."

According to Dr. Anandkumar, Chairman Board of Cellworks Research India Ltd, "The collaboration between Orchid Chemicals & Pharmaceuticals Ltd and Cellworks is ongoing in different drug discovery areas pertaining to Inflammation. It’s very exciting to note than an India based company is taking the lead in incorporating bleeding edge ideas into drug discovery related Research and Development. On behalf of Cellworks – we really appreciate this partnership opportunity and look forward to building up this collaborative research in coming years."